ENDRA Life Sciences (NDRA) Inventory (2016 - 2024)

ENDRA Life Sciences (NDRA) has reported Inventory for 9 consecutive years, with $2.7 million the latest figure, recorded in Q3 2024.

• On a quarterly basis, Inventory fell 1.66% year-over-year to $2.7 million in Q3 2024; TTM through Sep 2024 was $2.7 million, a 1.66% decrease from a year earlier, with the FY2023 full-year figure at $2.6 million, down 0.83% from the prior year.
• Inventory was $2.7 million for Q3 2024 at ENDRA Life Sciences, roughly flat from $2.7 million in the prior quarter.
• Over five years, Inventory peaked at $2.8 million in Q2 2023 and troughed at $174935.0 in Q1 2020.
• A 5-year average of $1.8 million and a median of $2.4 million in 2022 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 419.75% in 2020 and slipped 1.66% in 2024, its largest moves.
• Over 5 years, Inventory stood at $589620.0 in 2020, then surged by 117.87% to $1.3 million in 2021, then jumped by 105.88% to $2.6 million in 2022, then declined by 0.83% to $2.6 million in 2023, then increased by 3.4% to $2.7 million in 2024.
• The last three Inventory figures came in at $2.7 million (Q3 2024), $2.7 million (Q2 2024), and $2.7 million (Q1 2024), per Business Quant data.